| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Ellagic Acid | AGE Products | 2 | PM | 35097119 | 📋 | Physicochemical Characterization of In Vitro LDL Glycation and Its Inhibition by Ellagic Acid (EA): An In Vivo Approach to Inhibit Diabetes in Experimental Animals |
| Ellagic Acid | AGE Products | 1 | PM | 26242637 | 📋 | Anti-Glycation Effects of Pomegranate (Punica granatum L.) Fruit Extract and Its Components in Vivo and in Vitro |
| Ellagic Acid | Diabetes Type 2 | 3 | PM | 35844391 | 📋 | Ellagic acid regulates hyperglycemic state through modulation of pancreatic IL-6 and TNF- α immunoexpression |
| Ellagic Acid | Diabetes Type 2 | 2 | PM | 33955004 | 📋 | Subclinical hypothyroidism contributes to poor glycemic control in patients with type 2 diabetes mellitus, and ellagic acid attenuates methimazole-induced abnormal glucose metabolism in mice model |
| Ellagic Acid | Diabetes Type 2 | 7 | PM | 33546744 | 📋 | Decreased insulin resistance in diabetic patients by influencing Sirtuin1 and Fetuin-A following supplementation with ellagic acid: a randomized controlled trial |
| Ellagic Acid | Diabetes Type 2 | 6 | PM | 33287432 | 📋 | Ellagic Acid as a Tool to Limit the Diabetes Burden: Updated Evidence |
| Ellagic Acid | Diabetes Type 2 | 1 | PM | 32909365 | 📋 | Randomized double-blind clinical trial examining the Ellagic acid effects on glycemic status, insulin resistance, antioxidant, and inflammatory factors in patients with type 2 diabetes |
| Ellagic Acid | Diabetes Type 2 | 4 | PM | 29693586 | 📋 | Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats |
| Ellagic Acid | Diabetes Type 2 | 8 | PM | 29103827 | 📋 | Hybrid drug combination: Anti-diabetic treatment of type 2 diabetic Wistar rats with combination of ellagic acid and pioglitazone |
| Ellagic Acid | Diabetes Type 2 | 9 | PM | 28092161 | 📋 | Estimation of ellagic acid and/or repaglinide effects on insulin signaling, oxidative stress, and inflammatory mediators of liver, pancreas, adipose tissue, and brain in insulin resistant/type 2 diabetic rats |
| Ellagic Acid | Diabetes Type 2 | 5 | PM | 27633111 | 📋 | Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms |
| Ellagic Acid | Diabetes Type 2 | 10 | PM | 26593435 | 📋 | Ellagic acid in Emblica officinalis exerts anti-diabetic activity through the action on β-cells of pancreas |
| Ellagic Acid | Excessive Weight | 1 | PM | 33339214 | 📋 | Unripe Rubus coreanus Miquel Extract Containing Ellagic Acid Promotes Lipolysis and Thermogenesis In Vitro and In Vivo |
| Ellagic Acid | Glucose Metabolism Disorder | 2 | PM | 35844391 | 📋 | Ellagic acid regulates hyperglycemic state through modulation of pancreatic IL-6 and TNF- α immunoexpression |
| Ellagic Acid | Glucose Metabolism Disorder | 1 | PM | 33955004 | 📋 | Subclinical hypothyroidism contributes to poor glycemic control in patients with type 2 diabetes mellitus, and ellagic acid attenuates methimazole-induced abnormal glucose metabolism in mice model |
| Ellagic Acid | Hypercholesterolemia | 1 | PM | 36838229 | 📋 | Supplementation of Weizmannia coagulans BC2000 and Ellagic Acid Inhibits High-Fat-Induced Hypercholesterolemia by Promoting Liver Primary Bile Acid Biosynthesis and Intestinal Cholesterol Excretion in Mice |
| Ellagic Acid | Hypercholesterolemia | 2 | PM | 27845788 | 📋 | Effects of pomegranate peel polyphenols on lipid accumulation and cholesterol metabolic transformation in L-02 human hepatic cells via the PPARγ-ABCA1/CYP7A1 pathway |
| Ellagic Acid | Hyperglycemia | 2 | PM | 36233611 | 📋 | Ellagic Acid Effect on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
| Ellagic Acid | Hyperglycemia | 1 | PM | 34329744 | 📋 | Combined treatment of sinapic acid and ellagic acid attenuates hyperglycemia in streptozotocin-induced diabetic rats |
| Ellagic Acid | Hyperlipidemia | 4 | PM | 34202121 | 📋 | Ellagic Acid Suppresses ApoB Secretion and Enhances ApoA-1 Secretion from Human Hepatoma Cells, HepG2 |
| Ellagic Acid | Hyperlipidemia | 2 | PM | 29103458 | 📋 | Pomegranate leaf attenuates lipid absorption in the small intestine in hyperlipidemic mice by inhibiting lipase activity |
| Ellagic Acid | Hyperlipidemia | 3 | PM | 27633111 | 📋 | Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms |
| Ellagic Acid | Hyperlipidemia | 1 | PM | 25579987 | 📋 | Effects of ellagic acid-rich extract of pomegranates peel on regulation of cholesterol metabolism and its molecular mechanism in hamsters |
| Ellagic Acid | Hyperlipidemia | 5 | PM | 23058930 | 📋 | Ellagic acid inhibits cardiac arrhythmias, hypertrophy and hyperlipidaemia during myocardial infarction in rats |
| Ellagic Acid | Hypertriglyceridemia | 1 | PM | 36233611 | 📋 | Ellagic Acid Effect on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
| Ellagic Acid | Insulin Resistance | 8 | PM | 36235858 | 📋 | Weizmannia coagulans BC2000 Plus Ellagic Acid Inhibits High-Fat-Induced Insulin Resistance by Remodeling the Gut Microbiota and Activating the Hepatic Autophagy Pathway in Mice |
| Ellagic Acid | Insulin Resistance | 7 | PM | 36233611 | 📋 | Ellagic Acid Effect on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
| Ellagic Acid | Insulin Resistance | 6 | PM | 34330312 | 📋 | Randomized double blind clinical trial evaluating the Ellagic acid effects on insulin resistance, oxidative stress and sex hormones levels in women with polycystic ovarian syndrome |
| Ellagic Acid | Insulin Resistance | 5 | PM | 33955004 | 📋 | Subclinical hypothyroidism contributes to poor glycemic control in patients with type 2 diabetes mellitus, and ellagic acid attenuates methimazole-induced abnormal glucose metabolism in mice model |
| Ellagic Acid | Insulin Resistance | 4 | PM | 33546744 | 📋 | Decreased insulin resistance in diabetic patients by influencing Sirtuin1 and Fetuin-A following supplementation with ellagic acid: a randomized controlled trial |
| Ellagic Acid | Insulin Resistance | 1 | PM | 32783299 | 📋 | Ellagic Acid and Its Microbial Metabolite Urolithin A Alleviate Diet-induced Insulin Resistance in Mice |
| Ellagic Acid | Insulin Resistance | 2 | PM | 29693586 | 📋 | Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats |
| Ellagic Acid | Insulin Resistance | 3 | PM | 27633111 | 📋 | Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms |
| Ellagic Acid | Insulin Resistance | 9 | PM | 25356824 | 📋 | Gallic acid regulates body weight and glucose homeostasis through AMPK activation |
| Ellagic Acid | Metabolic Disorders | 2 | PM | 37814948 | 📋 | Ellagic acid reduces hepatic lipid contents through regulation of SIRT1 and AMPK in old rats |
| Ellagic Acid | Metabolic Disorders | 3 | PM | 32432341 | 📋 | Effect of phenolic compounds from the leaves of Psidium guajava on the activity of three metabolism-related enzymes |
| Ellagic Acid | Metabolic Disorders | 4 | PM | 29604377 | 📋 | Pomegranate polyphenols and urolithin A inhibit α-glucosidase, dipeptidyl peptidase-4, lipase, triglyceride accumulation and adipogenesis related genes in 3T3-L1 adipocyte-like cells |
| Ellagic Acid | Metabolic Disorders | 1 | PM | 27142738 | 📋 | Raspberry seed flour attenuates high-sucrose diet-mediated hepatic stress and adipose tissue inflammation |
| Ellagic Acid | Metabolic Disorders | 5 | PM | 25356824 | 📋 | Gallic acid regulates body weight and glucose homeostasis through AMPK activation |
| Ellagic Acid | Metabolic Syndrome | 4 | PM | 38027887 | 📋 | The effect of ellagic acid on the metabolic syndrome: A review article |
| Ellagic Acid | Metabolic Syndrome | 2 | PM | 36233611 | 📋 | Ellagic Acid Effect on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
| Ellagic Acid | Metabolic Syndrome | 1 | PM | 33671116 | 📋 | Ellagic Acid Affects Metabolic and Transcriptomic Profiles and Attenuates Features of Metabolic Syndrome in Adult Male Rats |
| Ellagic Acid | Metabolic Syndrome | 3 | PM | 22538930 | 📋 | Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats |
| Ellagic Acid | Mitochondrial Dysfunction | 1 | PM | 33276407 | 📋 | Stabilization of Mitochondrial Function by Ellagic Acid Prevents Celecoxib-induced Toxicity in Rat Cardiomyocytes and Isolated Mitochondria |
| Ellagic Acid | Obesity | 3 | PM | 33956354 | 📋 | Ellagic acid induces beige remodeling of white adipose tissue by controlling mitochondrial dynamics and SIRT3 |
| Ellagic Acid | Obesity | 1 | PM | 27633111 | 📋 | Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms |
| Ellagic Acid | Obesity | 2 | PM | 24302962 | 📋 | Ellagic Acid Reduces Adipogenesis through Inhibition of Differentiation-Prevention of the Induction of Rb Phosphorylation in 3T3-L1 Adipocytes |
